W
Wen Wee Ma
Researcher at Mayo Clinic
Publications - 139
Citations - 8618
Wen Wee Ma is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 28, co-authored 115 publications receiving 7106 citations. Previous affiliations of Wen Wee Ma include Translational Genomics Research Institute & Johns Hopkins University.
Papers
More filters
Journal ArticleDOI
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff,Thomas J. Ervin,Francis P. Arena,E. Gabriela Chiorean,Jeffrey R. Infante,Malcolm J. Moore,Thomas E. Seay,Sergei Tjulandin,Wen Wee Ma,Mansoor N. Saleh,Marion Harris,Michele Reni,Scot Dowden,Daniel A. Laheru,Nathan Bahary,Ramesh K. Ramanathan,Josep Tabernero,Manuel Hidalgo,David Goldstein,Eric Van Cutsem,Xinyu Wei,Jose Iglesias,Markus F. Renschler +22 more
TL;DR: In patients with metastatic pancreatic adenocarcinoma, nab-paclitaxel plus gemcitabine significantly improved overall survival, progression-free survival, and response rate, but rates of peripheral neuropathy and myelosuppression were increased.
Journal ArticleDOI
Pancreatic Adenocarcinoma, Version 2.2014
Margaret A. Tempero,Mokenge P. Malafa,Stephen W. Behrman,Al B. Benson,Ephraim S. Casper,E. Gabriela Chiorean,Vincent Chung,Steven J. Cohen,Brian G. Czito,Anitra Engebretson,Mary Feng,William G. Hawkins,Joseph M. Herman,John P. Hoffman,Andrew H. Ko,Srinadh Komanduri,Albert C. Koong,Andrew M. Lowy,Wen Wee Ma,Nipun B. Merchant,Sean J. Mulvihill,Peter Muscarella,Eric K. Nakakura,Jorge Obando,Martha B. Pitman,Sushanth Reddy,Aaron R. Sasson,Sarah P. Thayer,Colin D. Weekes,Robert A. Wolff,Brian M. Wolpin,Jennifer L. Burns,Deborah A. Freedman-Cass +32 more
TL;DR: These NCCN Guidelines Insights summarize major discussion points from the 2014 NCCn Pancreatic Adenocarcinoma Panel meeting, which focused mainly on the management of borderline resectable and locally advanced disease.
Journal ArticleDOI
Pancreatic Adenocarcinoma, Version 2.2012 Featured Updates to the NCCN Guidelines
Margaret A. Tempero,J. Pablo Arnoletti,Stephen Behrman,Edgar Ben-Josef,Al B. Benson,Ephraim S. Casper,Steven J. Cohen,Brian G. Czito,Joshua D. I. Ellenhorn,William G. Hawkins,Joseph M. Herman,John P. Hoffman,Andrew H. Ko,Srinadh Komanduri,Albert C. Koong,Wen Wee Ma,Mokenge P. Malafa,Nipun B. Merchant,Sean J. Mulvihill,Peter Muscarella,Eric K. Nakakura,Jorge Obando,Martha B. Pitman,Aaron R. Sasson,Anitra Tally,Sarah P. Thayer,Samuel Whiting,Robert A. Wolff,Brian M. Wolpin,Deborah A. Freedman-Cass,Dorothy A. Shead +30 more
TL;DR: The panel made 3 significant updates to the guidelines: more detail was added regarding multiphase CT techniques for diagnosis and staging of pancreatic cancer, and pancreas protocol MRI was added as an emerging alternative to CT.
Journal ArticleDOI
Novel Agents on the Horizon for Cancer Therapy
Wen Wee Ma,Alex A. Adjei +1 more
TL;DR: A recent review as mentioned in this paper highlights the pipeline of rationally designed drugs in clinical development that have the potential to impact clinical care in the near future and highlights the success of this target-based cancer drug development approach.
Journal Article
Pancreatic adenocarcinoma, version 2.2012
Margaret A. Tempero,J. Pablo Arnoletti,Stephen W. Behrman,Edgar Ben-Josef,Al B. Benson,Ephraim S. Casper,Steven J. Cohen,Brian G. Czito,Joshua D. I. Ellenhorn,William G. Hawkins,Joseph M. Herman,John P. Hoffman,Andrew H. Ko,Srinadh Komanduri,Albert C. Koong,Wen Wee Ma,Mokenge P. Malafa,Nipun B. Merchant,Sean J. Mulvihill,Peter Muscarella,Eric K. Nakakura,Jorge Obando,Martha B. Pitman,Aaron R. Sasson,Anitra Tally,Sarah P. Thayer,Samuel H. Whiting,Robert A. Wolff,Brian M. Wolpin,Deborah A. Freedman-Cass,Dorothy A. Shead +30 more